Skip to main content
. 2021 Sep 22;8:710738. doi: 10.3389/fmolb.2021.710738

TABLE 4.

Clinically approved RNA therapeutics.

Drug Molecule Target Disease Reference
mRNA-1273 mRNA Spike (S) protein of SARS-CoV-2 COVID-19 USFDA, (2021a)
BNT162b1 RBD of Spike glycoprotein USFDA, (2021b)
Patisiran siRNA Polyneuropathy Hereditary transthyretin-mediated amyloidosis Adams et al. (2018)
Givosiran siRNA ALAS1 AHP USFDA, (2019)
Pegaptanib Aptamer VEGF AMD Vinores, (2006)